APA (7th ed.) Citation

Appleton, E., Khosousi, S., Ta, M., Nalls, M., Singleton, A. B., Sturchio, A., . . . Svenningsson, P. (2024). DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson's disease. Translational Neurodegeneration, 13(1), 1. https://doi.org/10.1186/s40035-024-00421-0

Chicago Style (17th ed.) Citation

Appleton, Ellen, et al. "DOPA-decarboxylase Is Elevated in CSF, but Not Plasma, in Prodromal and De Novo Parkinson's Disease." Translational Neurodegeneration 13, no. 1 (2024): 1. https://doi.org/10.1186/s40035-024-00421-0.

MLA (9th ed.) Citation

Appleton, Ellen, et al. "DOPA-decarboxylase Is Elevated in CSF, but Not Plasma, in Prodromal and De Novo Parkinson's Disease." Translational Neurodegeneration, vol. 13, no. 1, 2024, p. 1, https://doi.org/10.1186/s40035-024-00421-0.